Pacira | PCRX - Assets

Stock Price
22.64
Daily Change
-0.89 -3.78%
Monthly
-5.11%
Yearly
-12.45%
Q2 Forecast
22.18

Pacira reported $1.21B in Assets for its fiscal quarter ending in March of 2026.





Assets Change Date
Assertio Holdings USD 319.77M 46M Sep/2025
Astellas Pharma JPY 3.57T 36.87B Mar/2026
Bristol-Myers Squibb USD 86.48B 3.56B Mar/2026
Cara Therapeutics USD 32.07M 6.95M Dec/2025
Coherus Biosciences USD 258.34M 258.18M Dec/2025
Heron Therapeutics USD 246.22M 9.66M Mar/2026
Ironwood Pharmaceuticals USD 434.57M 37.66M Mar/2026
J&J USD 200.89B 1.68B Mar/2026
Ligand Pharmaceuticals USD 1.53B 28.53M Mar/2026
Nektar Therapeutics USD 280.41M 20.94M Dec/2025
Novo Nordisk DKK 559.22B 16.32B Mar/2026
Omeros USD 200.57M 34.59M Jun/2025
Pacira USD 1.21B 56.38M Mar/2026
Perrigo USD 7.98B 551.9M Mar/2026
Pfizer USD 207.62B 542M Mar/2026
Supernus Pharmaceuticals USD 1.5B 48.08M Mar/2026
Teva Pharmaceutical Industries USD 40.04B 708M Mar/2026
Xeris Pharmaceuticals USD 392.01M 8.49M Mar/2026
Xoma USD 263.15M 39.7M Sep/2025
Zoetis USD 15.15B 313M Mar/2026